ARTMS Inc

ARTMS Inc is a medical isotope technology company based in Burnaby, British Columbia, Canada. The company operates in the field of medical isotopes, a specialized segment of the life sciences and nuclear medicine supply chain that provides radioactive materials used in diagnostic imaging and therapeutic procedures. Its location in the Metro Vancouver area places it within a recognized Canadian cluster of nuclear medicine and radiopharmaceutical activity. As a technology company, ARTMS is positioned at the intersection of nuclear science, engineering, and healthcare. Medical isotopes such as those used in positron emission tomography (PET) and other imaging modalities are essential inputs for hospitals and radiopharmacies, and the production and handling of these materials requires specialized equipment, regulatory compliance, and technical expertise. ARTMS is associated with this niche, supplying technology and related capabilities to the medical isotope sector. ARTMS is headquartered in Burnaby, British Columbia, and its official web presence is at artms.ca. The company is privately held. Detailed public information about its founding date, founders, ownership structure, and specific product lines is limited in the available evidence, and this dossier reflects that constraint rather than speculating beyond it. The company's identity is clearly commercial and technological: it is a corporate brand operating in the medical isotope technology space, not a consumer-facing brand. Its relevance lies in the specialized infrastructure and know-how required to produce and deliver medical isotopes reliably for healthcare systems.

ARTMS Inc is a medical isotope technology company headquartered in Burnaby, British Columbia, Canada. The available evidence identifies the company by its sector and location but does not provide a detailed corporate history, founding date, or list of founders. What can be stated with confidence is that ARTMS operates within the medical isotope technology field, a specialized area of the nuclear medicine and radiopharmaceutical industry. Medical isotopes are radioactive substances used in a range of clinical applications, most notably diagnostic imaging techniques such as positron emission tomography (PET), as well as certain therapeutic procedures. The production, purification, and distribution of these isotopes involve complex technical processes and are subject to stringent regulatory oversight. Companies in this space typically develop production technologies, equipment, and related services that enable hospitals, radiopharmacies, and research institutions to obtain the isotopes they need. ARTMS is based in Burnaby, part of the Metro Vancouver region of British Columbia. Canada has an established presence in nuclear science and medical isotope production, and the Vancouver area hosts a concentration of life sciences and radiopharmaceutical activity. ARTMS's location situates it within this ecosystem. The company maintains an official website at artms.ca. It is privately held, and no parent company, owner, or group affiliation is identified in the available evidence. Because the evidence is limited to a brief sector-and-location description, this history does not include dated milestones, funding events, product launches, or leadership changes; such details are not supported by the supplied sources and are therefore omitted rather than estimated.

Specialized medical isotope technology provider within the nuclear medicine and radiopharmaceutical supply chain.

Product categories. Medical isotope technology · Radiopharmaceutical production technology

1. 1ARTMS Inc — Wikidatawikidata.org
2. 2ARTMS schließt eine Serie A-Finanzierung in Höhe von 19 Millionen US-Dollar mit Deerfield und Global Health Sciences (GHS) Fund abfinanznachrichten.de